Cancermuts

Cancermuts automates retrieval and annotation of cancer missense mutations from cBioPortal and COSMIC and annotates them with REVEL pathogenicity scores plus protein-context features such as post-translational modification sites, structured and unstructured regions, and short linear motifs to prioritize variants.


Key Features:

  • Database integration: Retrieves known missense cancer mutations from cBioPortal and COSMIC and records mutation sources.
  • Pathogenicity scoring: Annotates variants with REVEL pathogenicity scores.
  • Protein-context annotation: Maps post-translational modification sites, structured and unstructured regions, and short linear motifs onto protein sequences.
  • Contextual classification: Classifies mutations by REVEL score, sequence position, and local protein context.
  • Analysis of intrinsically disordered proteins: Supports detailed annotation of intrinsically disordered proteins, exemplified by AMBRA1.
  • Variant prioritization linked to experiments: Prioritized mutations that were experimentally validated, including two AMBRA1 variants with enhanced tumorigenic potential.
  • Target-agnostic input: Operates starting from minimal information for any protein target.

Scientific Applications:

  • Prioritization of pathogenic variants: Ranks missense mutations for downstream functional assessment in cancer genomics.
  • Contextual functional interpretation: Assesses potential functional impact via proximity to PTMs, structured regions, disordered regions, and short linear motifs.
  • Study of intrinsically disordered proteins: Enables analysis of mutation effects in proteins like AMBRA1 that contain disordered regions.
  • Experimental candidate selection: Identifies mutations for cellular and molecular validation, including studies in melanoma.

Methodology:

Implemented in Python; retrieves mutations from cBioPortal and COSMIC; annotates variants with REVEL scores and mutation source; maps post-translational modification sites, structured/unstructured regions, and short linear motifs; and classifies mutations by REVEL score, sequence position, and local context.

Topics

Details

License:
GPL-3.0
Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux
Programming Languages:
Python
Added:
12/23/2022
Last Updated:
11/24/2024

Operations

Publications

Tiberti M, Di Leo L, Vistesen MV, Kuhre RS, Cecconi F, De Zio D, Papaleo E. The Cancermuts software package for the prioritization of missense cancer variants: a case study of AMBRA1 in melanoma. Cell Death & Disease. 2022;13(10). doi:10.1038/s41419-022-05318-2. PMID:36243772. PMCID:PMC9569343.

PMID: 36243772
PMCID: PMC9569343
Funding: - Kræftens Bekæmpelse: R204-A12424, R231-A14034 - Danmarks Grundforskningsfond: DNRF125 - LEO Pharma Research Foundation: LF-OC-19-000004, LF17024 - Melanoma Research Alliance: MRA 620385 - Carlsbergfondet: CF-0314

Documentation